Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

René-Marc Flipo

Showing results (1-10 of 196) with videos related to

Pageof 20
Sort By:
Presse Medicale (Paris, France : 1983)|November 3, 2006
[Are the NSAIDs able to compromising the cardio-preventive efficacy of aspirin?]René-Marc Flipo
Presse Medicale (Paris, France : 1983)|March 20, 2008
[Are the NSAIDs able to compromising the cardio-preventive efficacy of aspirin?]René-Marc Flipo
Soins; La Revue De Reference Infirmiere|November 2, 2004
[New treatments for rheumatoid arthritis]Véronique Girault, René-Marc Flipo
Presse Medicale (Paris, France : 1983)|February 7, 2004
[Physician and patient knowledge of NSAID digestive complication risks]René-Marc Flipo, Philippe Bertin
Clinical Rheumatology|October 1, 2013
Gout: from international guidelines to current practice. Results from a physician questionnaireTristan Pascart, René-Marc Flipo
Presse Medicale (Paris, France : 1983)|February 7, 2004
[What treatments can reduce the digestive complications of NSAIDs]Bernard Combe, René-Marc Flipo
Drug Design, Development and Therapy|July 29, 2016
An appraisal of golimumab in the treatment of severe, active nonradiographic axial spondyloarthritisJulien Paccou, René-Marc Flipo
Presse Medicale (Paris, France : 1983)|February 7, 2004
[Is it possible to rate digestive toxicities of NSAIDs?]Jean-Pierre Valat, René-Marc Flipo
Seminars in Musculoskeletal Radiology|October 26, 2005
MR imaging appearance of rheumatoid arthritis in the footNathalie Boutry, René-Marc Flipo, Anne Cotten
Presse Medicale (Paris, France : 1983)|December 6, 2007
[Which information should be given to the patient concerning the cardiovascular and renal risk of the NSAIDs?]René-Marc Flipo, François Héloire, Gilbert Deray
Pageof 20

Showing results (1-10 of 196) with videos related to

Sort By:
Pageof 20
Presse Medicale (Paris, France : 1983)|November 3, 2006
[Are the NSAIDs able to compromising the cardio-preventive efficacy of aspirin?]René-Marc Flipo
Presse Medicale (Paris, France : 1983)|March 20, 2008
[Are the NSAIDs able to compromising the cardio-preventive efficacy of aspirin?]René-Marc Flipo
Soins; La Revue De Reference Infirmiere|November 2, 2004
[New treatments for rheumatoid arthritis]Véronique Girault, René-Marc Flipo
Presse Medicale (Paris, France : 1983)|February 7, 2004
[Physician and patient knowledge of NSAID digestive complication risks]René-Marc Flipo, Philippe Bertin
Clinical Rheumatology|October 1, 2013
Gout: from international guidelines to current practice. Results from a physician questionnaireTristan Pascart, René-Marc Flipo
Presse Medicale (Paris, France : 1983)|February 7, 2004
[What treatments can reduce the digestive complications of NSAIDs]Bernard Combe, René-Marc Flipo
Drug Design, Development and Therapy|July 29, 2016
An appraisal of golimumab in the treatment of severe, active nonradiographic axial spondyloarthritisJulien Paccou, René-Marc Flipo
Presse Medicale (Paris, France : 1983)|February 7, 2004
[Is it possible to rate digestive toxicities of NSAIDs?]Jean-Pierre Valat, René-Marc Flipo
Seminars in Musculoskeletal Radiology|October 26, 2005
MR imaging appearance of rheumatoid arthritis in the footNathalie Boutry, René-Marc Flipo, Anne Cotten
Presse Medicale (Paris, France : 1983)|December 6, 2007
[Which information should be given to the patient concerning the cardiovascular and renal risk of the NSAIDs?]René-Marc Flipo, François Héloire, Gilbert Deray
Pageof 20